These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1176735)

  • 1. Letter: Electronegative groups at C-3 of rifamycin S enhance its activity toward DNA-dependent RNA polymerase.
    Dampier MF; Whitlock HW
    J Am Chem Soc; 1975 Oct; 97(21):6254-6. PubMed ID: 1176735
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of rifamycins with mammalian nucleic acid polymerizing enzymes.
    Sethi VS; Okano P
    Biochim Biophys Acta; 1976 Dec; 454(2):230-47. PubMed ID: 63293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of structure and activity in ansamycins: structure, conformation, and interactions of antibiotic rifamycin S.
    Arora SK
    J Med Chem; 1985 Aug; 28(8):1099-102. PubMed ID: 4020831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of Saccharomyces cerevisiae RNA polymerase by rifamycin derivatives (rifamycins and yeast RNA polymerase).
    Di Mauro E; Mezzina M; Arcà M
    Arch Biochem Biophys; 1974 Oct; 164(2):765-8. PubMed ID: 4618080
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of isolated yeast and mycelial phase RNA polymerases of Histoplasma capsulatum by rifamycin derivatives.
    McMillian R; Medoff G; Schlessinger D; Kobayashi GS
    Sabouraudia; 1977 Nov; 15(3):257-61. PubMed ID: 601661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of rifamazine, a member of a new class of (dimeric) rifamycins.
    Fietta AM; Silvestri LG
    Eur J Biochem; 1975 Mar; 52(2):391-400. PubMed ID: 51795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular structure and conformation of rifamycin S, a potent inhibitor of DNA-dependent RNA polymerase.
    Arora SK; Arjunan P
    J Antibiot (Tokyo); 1992 Mar; 45(3):428-31. PubMed ID: 1577671
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases.
    Czerwonka D; Domagalska J; Pyta K; Kubicka MM; Pecyna P; Gajecka M; Przybylski P
    Eur J Med Chem; 2016 Jun; 116():216-221. PubMed ID: 27061985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the topography of the binding site of DNA-dependent RNA polymerase from Escherichia coli for the antibiotic rifamycin SV.
    Stender W; Scheit KH
    Eur J Biochem; 1977 Jun; 76(2):591-600. PubMed ID: 330165
    [No Abstract]   [Full Text] [Related]  

  • 11. [RNA polymerase-rifamycin. A molecular model of inhibition].
    Chertov OIu; Obukhov AN; Lipkin VM
    Bioorg Khim; 1983 May; 9(5):633-40. PubMed ID: 6207842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical modifications of the aliphatic bridge of ansamycins. Synthesis and activity of 25-deacetoxy-25-epi-hydroxyrifamycin S.
    Brizzi V; Brufani M; Cellai L; Segre AL
    J Antibiot (Tokyo); 1983 May; 36(5):516-21. PubMed ID: 6874570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the effect of different rifamycins on bacterial cell metabolism and on the RNA-polymerase reaction in a cell-free system].
    Subbotina NA
    Antibiotiki; 1978 Mar; 23(3):239-42. PubMed ID: 345958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modification of DNA-dependent RNA polymerase from Escherichia coli by an alkylating derivative of rifamycin SV.
    Stender W; Stütz AA; Scheit KH
    Eur J Biochem; 1975 Aug; 56(1):129-36. PubMed ID: 1100387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal DNA-dependent RNA polymerases. 4. Studies on inhibition by rifamycin derivatives.
    Meilhac M; Tysper Z; Chambon P
    Eur J Biochem; 1972 Jul; 28(2):291-300. PubMed ID: 4560736
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes.
    Tsai MJ; Saunders GF
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2072-6. PubMed ID: 4516206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.
    Artsimovitch I; Vassylyeva MN; Svetlov D; Svetlov V; Perederina A; Igarashi N; Matsugaki N; Wakatsuki S; Tahirov TH; Vassylyev DG
    Cell; 2005 Aug; 122(3):351-63. PubMed ID: 16096056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The affinity of E. coli RNA polymerase to matrix bound rifamycin.
    Scheit KH; Stütz A
    FEBS Lett; 1975 Jan; 50(1):25-7. PubMed ID: 1089069
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of three nucleotide polymerases by rifamycin derivatives.
    Thompson FM; Tischler AN; Adams J; Calvin M
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):107-9. PubMed ID: 4129799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.